These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34444157)

  • 1. Modeling SF-6D Health Utilities: Is Bayesian Approach Appropriate?
    Kharroubi SA
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian modeling of health state preferences: could borrowing strength from existing countries' valuations produce better estimates.
    Kharroubi SA; Beyh Y
    Eur J Health Econ; 2021 Jul; 22(5):773-788. PubMed ID: 33761028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valuation of preference-based measures: can existing preference data be used to generate better estimates?
    Kharroubi SA
    Health Qual Life Outcomes; 2018 Jun; 16(1):116. PubMed ID: 29866108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of Hong Kong and United Kingdom SF-6D health states valuations using a nonparametric Bayesian method.
    Kharroubi SA; Brazier JE; McGhee S
    Value Health; 2014 Jun; 17(4):397-405. PubMed ID: 24969000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valuation of preference-based measures: can existing preference data be used to select a smaller sample of health states?
    Kharroubi SA; Rowen D
    Eur J Health Econ; 2019 Mar; 20(2):245-255. PubMed ID: 29980950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Bayesian methods to model the SF-6D health state preference based data.
    Kharroubi SA
    Health Qual Life Outcomes; 2018 Dec; 16(1):234. PubMed ID: 30563528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling SF-6D health state preference data using a nonparametric Bayesian method.
    Kharroubi SA; Brazier JE; Roberts J; O'Hagan A
    J Health Econ; 2007 May; 26(3):597-612. PubMed ID: 17069909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian nonparametric estimation of EQ-5D utilities for United States using the existing United Kingdom data.
    Kharroubi SA
    Health Qual Life Outcomes; 2017 Oct; 15(1):195. PubMed ID: 28985757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the SF-6D value set for a population-based sample of Brazilians.
    Cruz LN; Camey SA; Hoffmann JF; Rowen D; Brazier JE; Fleck MP; Polanczyk CA
    Value Health; 2011; 14(5 Suppl 1):S108-14. PubMed ID: 21839880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a Non-parametric Bayesian Method to Model Health State Preferences: An Application to Polish and Irish EQ-5D-5L Valuations.
    Kharroubi SA; Kelleher D
    Front Public Health; 2022; 10():917728. PubMed ID: 35812518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Importance of Accounting for Parameter Uncertainty in SF-6D Value Sets and Its Impact on Studies that Use the SF-6D to Measure Health Utility.
    Kharroubi SA; Beyh Y; Abdul Fattah E; Young T
    Int J Environ Res Public Health; 2020 Jun; 17(11):. PubMed ID: 32498412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the SF-6Dv1 Value Set for a Population-Based Sample in Lebanon.
    Kharroubi SA; Mukuria C; Dawoud D; Rowen D
    Value Health Reg Issues; 2024 Jul; 42():100977. PubMed ID: 38340672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparison of Japan and U.K. SF-6D Health-State Valuations Using a Non-Parametric Bayesian Method.
    Kharroubi SA
    Appl Health Econ Health Policy; 2015 Aug; 13(4):409-20. PubMed ID: 25896874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian Nonparametric Approach for Modeling SF-6D Health State Utility Scores.
    Kharroubi SA
    Value Health Reg Issues; 2022; 27():1-11. PubMed ID: 34784542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the Feasibility and Acceptability of Valuing the Arabic Version of SF-6D in a Lebanese Population.
    Kharroubi SA; Beyh Y; Harake MDE; Dawoud D; Rowen D; Brazier J
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32041284
    [No Abstract]   [Full Text] [Related]  

  • 16. Modelling covariates for the SF-6D standard gamble health state preference data using a nonparametric Bayesian method.
    Kharroubi S; Brazier JE; O'Hagan A
    Soc Sci Med; 2007 Mar; 64(6):1242-52. PubMed ID: 17157971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of SF-6D health state valuation studies.
    Wang L; Poder TG
    J Med Econ; 2023; 26(1):584-593. PubMed ID: 36973235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating a preference-based index from the Japanese SF-36.
    Brazier JE; Fukuhara S; Roberts J; Kharroubi S; Yamamoto Y; Ikeda S; Doherty J; Kurokawa K
    J Clin Epidemiol; 2009 Dec; 62(12):1323-31. PubMed ID: 19615856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling SF-6D Hong Kong standard gamble health state preference data using a nonparametric Bayesian method.
    Kharroubi SA; Brazier JE; McGhee S
    Value Health; 2013; 16(6):1032-45. PubMed ID: 24041353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valuation of the SF-6D Health States Is Feasible, Acceptable, Reliable, and Valid in a Chinese Population.
    Lam CL; Brazier J; McGhee SM
    Value Health; 2008; 11(2):295-303. PubMed ID: 18380642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.